Tiziana Life Sciences plc: Total Voting Rights
LONDON and NEW YORK, July 31, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” […]
Red River Bank expanding to Lafayette, Louisiana area
ALEXANDRIA, La., July 31, 2020 (GLOBE NEWSWIRE) — Red River Bank announced that it intends to expand its operations to […]
Constellation Pharmaceuticals to Host Conference Call to Discuss Second Quarter 2020 Results
CAMBRIDGE, Mass., July 31, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to […]
Eagle Bulk Reports the Successful Resolution of Security Incident Onboard Vessel
STAMFORD, Conn., July 31, 2020 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle Bulk” or the “Company”), one […]
Seanergy Maritime Holdings Corp. Sets Date for the Second Quarter and Six Months Ended June 30, 2020 Financial Results, Conference Call and Webcast
Earnings Release: Wednesday, August 5, 2020, Before Market Opens in New YorkConference Call and Webcast: Wednesday, August 5, 2020, at […]
Denbury Resources Receives NYSE Notice of Immediate Suspension of Trading and Delisting of Denbury Common Stock
PLANO, Texas, July 31, 2020 (GLOBE NEWSWIRE) — Denbury Resources Inc. (NYSE: DNR) (“Denbury” or the “Company”) today was notified […]
Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative
SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision […]
Catalyst Pharmaceuticals Comments on Magistrate Judge’s Report and Recommendation in its Lawsuit against the FDA
CORAL GABLES, Fla., July 31, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), today reported that the Magistrate […]
Datametrex Awarded Contract Extension With US Air Force
TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G) is pleased to […]
UPDATE – Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty […]
